RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Clinical trials for RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for lymphoma patients who have run out of options
Disease control OngoingThis study tests an experimental drug called zilovertamab vedotin in 140 people with diffuse large B-cell lymphoma that has come back or not responded to at least two prior treatments. The goal is to see if the drug can shrink tumors and how long that effect lasts. Participants r…
Matched conditions: RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 26, 2026 11:22 UTC
-
Lymphoma combo drug study pulled before it even started
Disease control TerminatedThis study was designed to test the safety and effectiveness of combining the drug selinexor with other treatments for people whose diffuse large B-cell lymphoma had come back or stopped responding to therapy. It planned to enroll adults with this type of lymphoma who had already…
Matched conditions: RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Karyopharm Therapeutics Inc • Aim: Disease control
Last updated May 26, 2026 11:08 UTC